from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0455c/-

LFCtreatmentdescriptionclass of inhibitor

0.829

Amikacinug/mL Amikacintranslation

2.293

Cap5-10ug/mL Capreomycintranslation

2.167

Rox10-50 ug/mL Roxithromycintranslation

0.790

SM2-5 ug/mL Streptomycintranslation

1.220

Tet5-10 ug/mL Tetracyclinetranslation

-1.140

Rif0.2-5ug/mL Rifampicintranscription

-0.233

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.824

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.259

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.707

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.835

Clofazimine10-13 ug/mL Clofaziminerespiration

0.134

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.172

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.287

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.487

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.086

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.369

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.196

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.210

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.079

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.664

KCN5-20 ug/mL Potassium cyaniderespiration

0.668

NaN30.2-2 mM Sodium aziderespiration

0.789

Nigericin50 uM Nigericinrespiration

-0.159

TRC10-150 ug/mL Triclosanrespiration

-0.534

TRZ10-25 ug/mL Thioridazinerespiration

-1.276

Valinomycin0.5-10 uM Valinomycinrespiration

1.005

ZnSO42 mM ZnSO4respiration

0.078

menadione6-10 ug/mL Menadionerespiration

-0.225

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.471

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.211

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.815

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.334

NRP_1Non-replicating persistence stage 1dosRassociated

-0.001

Amp0.2mg/mL AmpicillincellWall

-0.158

Cephalexin20-100 ug/mL CephalexincellWall

0.295

Cerulenin0.32-5 ug/mL CerulenincellWall

0.516

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.451

EMB10-20 ug/mL EthambutolcellWall

0.390

Eta12-40 ug/mL EthionamidecellWall

0.768

INH0.2-0.4 ug/mL IsoniazidcellWall

1.028

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.180

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.807

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.294

BZA0.12 mg/mL BenzamidearomaticAmides

-0.542

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.835

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.178

H2O24 mM hydrogen peroxideDNAdamaging

1.568

Levo10 ug/mL LevofloxacinDNAdamaging

-0.213

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.758

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.855

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.462

UVUV-irradiationDNAdamaging

-0.217

ARP41-4 ug/mL Antitubercular compound ARP4?

0.093

Antimycin12.5-50 ug/mL Antimycin A?

0.235

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.455

PA_110-50 ug/mL Antitubercular compound PA-1?

0.577

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.054

PA8240.2-2 ug/mL PA-824?

-0.455

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.362

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.152

Verapamil50 uM Verapamil?

-0.231

mercaptoethanol2 mM 2-Mercaptoethanol?

0.224

methoxatin10-20 ug/mL Methoxatin?